Indication
Neovascular age-related macular degeneration
Neovascular age-related macular degeneration, commonly referred to as wet or exudative age-related macular degeneration, is an advanced, sight-threatening ocular disorder affecting the central retina in older adults. Read more about Neovascular age-related macular degeneration
21 drugs 15 manufacturers
Drugs that treat it
Common Neovascular age-related macular degeneration therapies.
CIMERLI (ranibizumab-eqrn)
EYLEA HD (aflibercept)
PAVBLU (aflibercept-ayyh)
CIMERLI (ranibizumab-eqrn)
BYOOVIZ (ranibizumab-nuna)
BEOVU (brolucizumab-dbll)
VISUDYNE (verteporfin)
NUFYMCO (ranibizumab-leyk)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNeovascular age-related macular degeneration, commonly referred to as wet or exudative age-related macular degeneration, is an advanced, sight-threatening ocular disorder affecting the central retina in older adults.
It is pathologically characterized by choroidal neovascularization, during which abnormal, fragile blood vessels proliferate from the choroid into the sub-retinal or sub-retinal pigment epithelium spaces.
Exudation from these permeable vessels leads to fluid leakage, intraretinal or subretinal hemorrhage, and progressive fibrovascular scar formation.
These structural changes disrupt the macula, precipitating rapid deterioration of sharp, high-acuity central vision, visual distortion, and the development of central scotomas.
- nih.gov
Neovascular age-related macular degeneration, commonly referred to as wet or exudative age-related macular degeneration, is an advanced, sight-threatening ocular disorder affecting the central retina in older adults It is pathologically characterized by choroidal neovascularization, during which abnormal, fragile blood vessels proliferate from the choroid into the sub-retinal or sub-retinal pigment epithelium spaces
- nih.gov
Neovascular age-related macular degeneration, commonly referred to as wet or exudative age-related macular degeneration, is an advanced, sight-threatening ocular disorder affecting the central retina in older adults These structural changes disrupt the macula, precipitating rapid deterioration of sharp, high-acuity central vision, visual distortion, and the development of central scotomas
- nih.gov
It is pathologically characterized by choroidal neovascularization, during which abnormal, fragile blood vessels proliferate from the choroid into the sub-retinal or sub-retinal pigment epithelium spaces Exudation from these permeable vessels leads to fluid leakage, intraretinal or subretinal hemorrhage, and progressive fibrovascular scar formation These structural changes disrupt the macula, precipitating rapid deterioration of sharp, high-acuity central vision, visual distortion, and the devel...
- nih.gov
It is pathologically characterized by choroidal neovascularization, during which abnormal, fragile blood vessels proliferate from the choroid into the sub-retinal or sub-retinal pigment epithelium spaces
- aao.org
Exudation from these permeable vessels leads to fluid leakage, intraretinal or subretinal hemorrhage, and progressive fibrovascular scar formation
- medlineplus.gov
These structural changes disrupt the macula, precipitating rapid deterioration of sharp, high-acuity central vision, visual distortion, and the development of central scotomas
Personalize your experience
Follow Neovascular age-related macular degeneration and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.